quarta-feira, 7 de outubro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· June 19, 2026

Could The S&P 500 Gain 30% This Year?

View original at finance.yahoo.com
Could The S&P 500 Gain 30% This Year? Stocks have been on a tear this year. We're still a couple of weeks away from the halfway mark, and already the Dow is up 7.4%, the S&P 500 is up 9.6%, and the tech-heavy Nasdaq is up 14.1%…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • The AI data center market could grow to $1 trillion by 2030

    60% confidence
  • Demand for AI is insatiable

    60% confidence
  • AI is the most powerful technology force of our time

    60% confidence
  • We are at the beginning of a new computing era

    60% confidence
  • The current AI bull market is comparable to the late 1990s tech boom

    60% confidence
  • We are on the cusp of a small-cap renaissance driven by rate cuts and 100% immediate capex expensing

    60% confidence
  • Nonfarm business productivity rose at a 2.8% annual rate in Q4 2025, above the 1.9% expectation; Q3 2025 revised to 5.2% from 4.9%

    60% confidence
  • AMD could grow by 35% a year for the next 3-5 years because of AI demand

    60% confidence
  • Half of a stock's price movement can be attributed to the group/industry it is in

    60% confidence
  • The S&P 500 could gain 30% or more in 2026, driven by AI boom, productivity growth, and strong earnings

    60% confidence
  • AI will revolutionize every industry, from healthcare to transportation

    60% confidence
  • Geopolitical conflicts and events usually only have a short-term impact on markets and markets usually bounce back fast

    60% confidence
  • Q2 2026 EPS growth is forecast at 21.8%, Q3 at 19.2%, Q4 at 21.1%

    60% confidence
  • The AI-driven bull market still has another year or two to run

    60% confidence
  • We will see 5 years in a row of double-digit market gains, analogous to 1995-1999; 2026 is year 4, 2027 is year 5

    60% confidence
  • The AI market is faster than anything we've seen before

    60% confidence
  • Stocks in the top 50% of Zacks Ranked Industries outperform those in the bottom 50% by a factor of 2 to 1

    60% confidence

Data points we hold from this source

S&P 500 Index Fund · eps21.1 percent_yoy_growth_forecast
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Autumn 2026 Biopharma Catalyst Season: Late-Breaking Data, FDA Milestones and the Rise of AI-Designed Drugs
Late-September and early-October 2026 conferences (EASD, EADV, IGCS) brought a cluster of positive late-breaking trial readouts. These covered obesity and metabolic disease (Novo Nordisk's CagriSema), immunology (Lilly's EBGLYSS, tulisokibart) and oncology (Rina-S, Agenus BOT+BAL). Ahead lie hard regulatory catalysts, led by the 14 Nov 2026 FDA PDUFA date for ivonescimab. At the same time, Insilico-style AI-designed drugs such as rentosertib are showing anti-aging signals. That points to AI-driven drug discovery moving from concept toward clinical validation. Unrelated tech and regulatory items (Tesla Cybercab probe, xAI litigation, OpenAI agent incident) and the speculative QAIAx claims are peripheral to this story.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,986
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,986 factos verificados com a fonte5,362 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
Could The S&P 500 Gain 30% This Year? — Source | Via News | pt.VIA.NEWS